|
|
Volumn 11, Issue 4, 2012, Pages 273-
|
|
Metabolic disease: Identifying novel targets of resveratrol
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENYLATE KINASE;
CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE;
CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE BETA;
CELL PROTEIN;
CYCLIC AMP;
EPAC1 PROTEIN;
LIVER ENZYME;
LIVER KINASE BETA 1;
MESSENGER RNA;
PHOSPHODIESTERASE I;
PHOSPHODIESTERASE III;
PHOSPHODIESTERASE VI;
PHOSPHOLIPASE C;
RESVERATROL;
ROLIPRAM;
RYANODINE RECEPTOR 2;
UNCLASSIFIED DRUG;
ARTICLE;
BASAL METABOLIC RATE;
DRUG EFFECT;
DRUG MECHANISM;
DRUG POTENCY;
DRUG RESPONSE;
ENZYME ACTIVATION;
ENZYME ACTIVITY;
ENZYME PHOSPHORYLATION;
HUMAN;
MOLECULAR DYNAMICS;
MOLECULAR INTERACTION;
NONHUMAN;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
PROTEIN DETERMINATION;
PROTEIN FUNCTION;
PROTEIN LOCALIZATION;
UPREGULATION;
|
|
EID: 84859311453
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3717 Document Type: Article |
|
Times cited : (7)
|
|
References (1)
|
